Ibogaine’s most striking effect is also its most misunderstood. Withdrawal stops. Craving — the constant preoccupation that made using feel like something other than a choice — largely lifts, often for months.
And then a person goes home.
Dr. Bruno Rasmussen, who has supervised more than 2,000 ibogaine treatments in Brazilian hospitals since 1994, puts the problem in a single observation: the craving goes away, but the patient may still use — because craving was never the whole reason. Something has to occupy the space it leaves.
That is what aftercare is. Not an add-on to treatment, and not a package upgrade: it is the part where recovery actually happens.
What the window is, and how long it stays open
It helps to think in three timescales, because they are frequently confused.
Days. Noribogaine, ibogaine’s long-acting metabolite, remains active in the body for days after the session ends. This is the medically hazardous period.
Weeks to months. The reduction in craving persists well beyond the acute effects. In the published Brazilian study, patients treated once reported a median of 5.5 months of abstinence; those treated more than once, 8.4 months.
The first 90 days. This is where relapse risk concentrates — the period when the pharmacological help is fading and whatever has replaced it either holds or does not.
The window is not indefinite, and that is the point. It is a period of unusual opportunity, and what gets built inside it determines what remains when it closes.
Ibogaine success rates explained →
The first week — the part people underestimate
Two things make the first week distinct.
It carries genuine medical risk. Ibogaine remains active. Tolerance has changed. And craving has lifted, which paradoxically makes this a moment when people feel safe experimenting. Returning to a previous dose of any substance during this period is not simply a relapse — it is a pharmacological interaction, and a meaningful share of deaths attributed to ibogaine involved exactly this.
The psychological material keeps working. The session’s content — the autobiographical memories most patients describe — does not stop being processed when the acute effects end. In the published protocol, patients were advised to avoid social activity for at least seven days afterwards, not out of excessive caution but because this material needs space rather than distraction.
Practically: rest, no substances of any kind including alcohol, someone present, and psychological support already scheduled rather than arranged in a hurry.
What good aftercare actually consists of
Psychotherapy — the non-negotiable part
In the programme behind the published Brazilian research, ibogaine is not regarded as the treatment. It is regarded as what makes treatment possible, and psychotherapy does the work — roughly four sessions before the treatment and four afterwards. Patients unwilling to take part are not accepted at all.
The reasoning is practical: the session can clear withdrawal and craving, but it is the psychological work that sustains the result.
The published research used cognitive-behavioural therapy. The specific modality matters less than the fact that structured psychological work is happening, with a therapist who understands what the patient has just been through.
Integration
“Integration” is used loosely in the psychedelic field, so it is worth defining concretely. It means turning what surfaced during the session into something usable.
Most patients describe autobiographical material appearing with unusual clarity — often relating directly to situations they had not been able to look at or make sense of. That is raw material, not a resolution. Integration is the work of examining it with a therapist, deciding what it means, and translating it into changes that hold when the clarity fades.
Without it, people are left with a vivid experience and no plan.
Relapse-prevention planning
Concrete and unglamorous: identifying the specific triggers, situations and relationships that preceded use; deciding in advance what happens when they arise; and agreeing who gets contacted when things become difficult.
The best time to make these decisions is while craving is absent and thinking is clear — which is exactly the window ibogaine opens.
Family involvement
Family support was an explicit inclusion criterion in the published protocol, and monitoring at home was carried out with family involvement.
There is a practical reason. A patient returns to an environment that other people occupy, and one that in many cases contributed to the problem. Families who understand what has happened, what to expect in the difficult weeks, and what not to do are a genuine part of the treatment rather than bystanders.
Monitoring and follow-up
Structured check-ins over the high-risk months, and in some programmes toxicology testing — not as surveillance, but because an early wobble handled quickly is a very different event from one discovered months later.
A clinic that follows its patients also knows its own outcomes. One that does not is guessing about its own results.
What aftercare is not
Three things are frequently sold as aftercare and are not.
A follow-up phone call. One check-in a fortnight after treatment is contact, not care.
A PDF of recovery tips. Generic material was not written for your case.
An invitation to book again. Repeat treatment can be clinically appropriate — the published data shows longer abstinence among patients treated more than once — but “come back when it wears off” is not a recovery plan.
When comparing programmes, ask what specifically happens in weeks 2, 6 and 12, and who provides it. Vague answers indicate that nothing has been designed.
How to choose an ibogaine clinic →
Beyond the secondary outcomes
There is a reason to think about aftercare in broader terms than relapse prevention.
Addiction treatment is increasingly evaluated on more than consumption — on craving, relationships, quality of life and self-efficacy, the sense of being able to manage one’s own behaviour. The reasoning is straightforward: someone who has stopped using but whose life has not changed has not really been treated, and is unlikely to stay stopped.
The 2016 qualitative study of the Brazilian programme found improvements across all of those measures. Those are not effects of a single session. They are what gets rebuilt over the months afterwards — relationships repaired, work resumed, confidence recovered.
Ibogaine can create the conditions. It cannot do the rebuilding.
What to arrange before you travel
Most aftercare failures are planning failures, and they are avoidable. Before treatment, have in place:
- A therapist at home — identified, briefed and with sessions booked, ideally starting within the first week back
- Time off — not returning to work the day after landing
- A named person who knows where you have been and what to watch for
- An honest plan for the environment you are returning to, including where the substance was easily available
- Scheduled clinic follow-up, with dates rather than intentions
- A decision made in advance about what happens if you use — agreed while thinking clearly, not in the moment
The people who do best are consistently those who treated the trip as the middle of the process rather than the end.
How we support this part
Our involvement does not end when a client is admitted. We stay in contact through treatment, help the clinic, the patient and the family stay on the same page, and help put aftercare in place — including support during the first 90 days, when relapse risk is highest.
We also weight aftercare heavily when recommending programmes. A cheaper option that ends at discharge is not cheaper in any sense that matters.
Free and confidential. We’ll set out what happens after treatment, not just during it — usually within 24 hours.